Page last updated: 2024-08-24

2,4-diaminopyridine and Local Neoplasm Recurrence

2,4-diaminopyridine has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, A; Chaturvedi, P; Dubrovskiy, A; Etter, J; Harding, TC; Haringsma, H; Karp, R; Labenski, MT; Lee, K; Martin, TS; Medikonda, A; Nacht, M; Niu, D; Petter, RC; Raponi, M; Ren, Y; Sheets, M; Simmons, AD; Singh, J; Tester, R; Tjin Tham Sjin, R; Walter, AO; Westlin, WF; Zhu, Z	1

Other Studies

1 other study(ies) available for 2,4-diaminopyridine and Local Neoplasm Recurrence

Article	Year
In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing. Molecular cancer therapeutics, 2014, Volume: 13, Issue:6 Topics: 4-Aminopyridine; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Drug Resistance, Neoplasm; ErbB Receptors; Humans; In Vitro Techniques; Mice; Mutation; Neoplasm Recurrence, Local; Xenograft Model Antitumor Assays	2014

Article

Year

In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing.

Molecular cancer therapeutics, 2014, Volume: 13, Issue:6

Topics: 4-Aminopyridine; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Drug Resistance, Neoplasm; ErbB Receptors; Humans; In Vitro Techniques; Mice; Mutation; Neoplasm Recurrence, Local; Xenograft Model Antitumor Assays

2014